Four Pathology & Laboratory Medicine Faculty Named "Positive Champion of the Learning Environment" by WAMS
Drs. Luba Dumeno, L. Corey Hanley, Joyce Ou, and Mariana Canepa were each identified as a "positive champion of the learning environment" by Warren Alpert Medical School.
At any point during their education, students may nominate faculty for demonstrating exemplary behaviors that promote a positive learning environment. This often includes a focus on respectful education, the creation of an environment that is welcoming to all students, providing clear expectations and appropriate feedback, and more.
New Study by Jake Kurtis and Colleagues named one of NIAID's Women's Health Research Advances - FY 2018
The study, conducted in 647 mother-infant pairs examined the role of maternal antibodies in protecting infants from malaria infection and disease. This study is the first demonstration that antibodies to a specific malaria protein, SEA-1, from the mother can confer resistance to severe malaria or death in the offspring. The results also suggest that vaccinating pregnant women with PfSEA-1 could help their infants survive malaria infection.
Jake Kurtis received a 2018 OVPR research seed award to identify novel drugs for the treatment of falciparum malaria in children.
Joyce Ou, MD, PhD, Associate Professor of Pathology, was awarded $75,000 by Swim Across America in December 2018 in support of her research entitled “Genomic signatures of tumor evolution: a search for novel markers of endometrial cancer”. Dr. Ou has received $317,000 from Swim Across America in the last 5 years.
C. James Sung, MD, Professor of Pathology, was awarded $20,000 by the Luke Charitable Foundation of Rhode Island in December 2018 in support of the International Visiting Fellowship in Gynecologic Pathology, Breast Pathology and Perinatal Pathology. The current year international visiting fellows are Jonathan Wawire, MD, from Aga Khan University of Kenya and Lennie Quimio, MD, from Dr. Jose Fabella Memorial Hospital, Manila, Philippines. The Luke Charitable Foundation has supported the education of international visiting fellows in Women’s Pathology since 2011.
Dr. Murray Resnick named Vice Chair for Translational Research in the Department of Pathology and Laboratory Medicine
It is a great pleasure to announce the appointment of Dr. Murray Resnick, MD, PhD as Vice Chair for Translational Research in the Department of Pathology and Laboratory Medicine.
Dr. Resnick is currently the Directory of Anatomic and Gastrointestinal Pathology and Vice-Chief of Pathology at the Rhode Island and Miriam Hospitals. He serves as Director of the Molecular Pathology core facility of the COBRE Center for Cancer Research and is Professor of Pathology and Laboratory Medicine at the Warren Alpert Medicine School at Brown University.
Dr. Resnick’s own research interests are in the general field of biomarkers of neoplastic and non-neoplastic gastrointestinal diseases. Recent foci of interest include the identification of novel diagnostic markers of eosinophilic esophagitis and characterization of the immune and stromal microenvironment in colorectal and breast tumors. Dr. Resnick has expertise in the utilization of image analysis and artificial intelligence in surgical and experimental pathology.
Dr. Resnick is active in several international and national pathology organizations including chairing the Publications Committee of the United States and Canadian Academy of Pathology and serves on council of Association of Directors of Anatomic Pathology. He serves on the editorial board of several leading pathology journals including laboratory Investigation, Modern Pathology, and Human Pathology.
As Vice Chair for Translational Research, Dr. Resnick will identify, foster and support opportunities to enhance the translation of basic science discoveries toward clinical relevance. Specifically, he will serve as a liaison between basic science faculty, largely but not exclusively based at the University, with clinical faculty based in the Departments of Pathology at the affiliated hospitals. He will work on forging collaborative projects which will lead to greater funding opportunities and strengthening of the academic mission of our Department and the Medical School.
Please join us in welcoming Murray to this critical new role.
Jake Kurtis, MD, PhD
Douglas Anthony, MD, PhD
"Cancer therapy shows promise for some brain tumors"
It gives us great pleasure to announce that, following a national search, Wafik El-Deiry, MD, PhD, FACP will join the Department of Pathology and Laboratory Medicine at The Warren Alpert Medical School of Brown University and Lifespan hospitals, and the Division of Hematology/Oncology within the Department of Medicine and the Lifespan Cancer Institute, in January.
Dr. El-Deiry, an internationally recognized physician-scientist with expertise in cancer biology and clinical training in oncology, will serve as the inaugural director of the Brown-Lifespan Joint Program in Cancer Biology and as the inaugural Associate Dean for Oncologic Sciences at Brown University. In these roles he will work to develop a basic and translational cancer research program of national and international stature with the goal of advancing cancer diagnosis, treatment, and prevention. The program will simultaneously contribute to the training of graduate students and postgraduate fellows, including those from hematology/oncology, pathology, and pediatrics. He will work with Jack A. Elias, MD, senior vice president for health affairs and dean of medicine and biological sciences, and key stakeholders at Lifespan hospitals to catalyze and facilitate collaborative, innovative, patient-centered oncologic research across Brown and Lifespan.
Dr. El-Deiry received his medical degree and PhD from the University of Miami School of Medicine and completed internal medicine residency and medical oncology fellowship training at the Johns Hopkins Hospital and Johns Hopkins Oncology Center, where he also completed postdoctoral training with the renowned Bert Vogelstein, MD. He comes to us from Fox Chase Cancer Center in Philadelphia.
In Dr. El-Deiry, we believe we have found the ideal physician-scientist leader and role model for our students and fellows. As a practicing oncologist, and specialist in gastrointestinal oncology, and one who initiates clinical trials based on laboratory discoveries, we look forward to seeing the impact of cancer research in the clinic.
Dr. El-Deiry is an American Cancer Society Research Professor and, since 2014, has served as deputy director for translational research and co-leader of the Molecular Therapeutics Program at Fox Chase Cancer Center. Prior to that, he served as the chief of Hematology/Oncology and associate director of the Cancer Institute at Penn State University, and as a tenured professor of medicine, genetics, and pharmacology at the University of Pennsylvania Perelman School of Medicine, and co-program leader at the Abramson Comprehensive Cancer Center.
Dr. El-Deiry has published over 280 papers, has an H index of 110, and is the principal investigator on two National Institutes of Health (NIH) research grants and several industry grants supporting clinical trials. He has been continuously funded by the National Cancer Institute for two decades and currently serves as the chair of an NIH Study Section.
Dr. El-Deiry is an elected member of the American Society for Clinical Investigation, the Association of American Physicians, the Interurban Clinical Club (President, 2013-2014), and the Johns Hopkins Society of Scholars. He is a fellow of the American College of Physicians.
Dr. El-Deiry’s laboratory will be located in the 70 Ship Street building and he will participate in the clinical and teaching activities of the pathology and hematology/oncology services at Lifespan. He will care for patients with colorectal cancer at the Lifespan Cancer Institute.
Please join us in welcoming Dr. El-Deiry.
Jonathan Kurtis, MD, PhD
Stanley M. Aronson Professor of Pathology and Laboratory Medicine
Chair of the Department of Pathology and Laboratory Medicine
Howard Safran, MD
Chief, Hematology Oncology
Professor of Medicine
A new $9.4 million federal grant to Lifespan will create a Center for Biomedical Research Excellence (COBRE) that will help researchers from The Miriam and Rhode Island hospitals discover ways to help address the worldwide threat of drug-resistant "superbugs." Learn more about the grant and our world-renowned researchers' work.